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ABSTRACT
￿
PC12 cells, which differentiate morphologically and biochemically into sympathetic
neuronlike cells in response to nerve growth factor, also respond to epidermal growth factor.
The response to epidermal growth factor is similar in certain respects to the response to nerve
growth factor. Both peptides produce rapid increases in cellular adhesion and 2-deoxyglucose
uptake and both induce ornithine decarboxylase. But nerve growth factor causes a decreased
cell proliferation and a marked hypertrophy of the cells. In contrast, epidermal growth factor
enhances cell proliferation and does not cause hypertrophy. Nerve growth factor induces the
formation of neurites; epidermal growth factor does not.
When both factors are presented simultaneously, the cells form neurites. Furthermore, the
biological response to epidermal growth factor, as exemplified by the induction of ornithine
decarboxylase, is attenuated by prior treatment of the cells with nerve growth factor.
PC12 cells have epidermal growth factor receptors. The binding of epidermal growth factor
to these receptors is rapid and specific, and exhibits an equilibrium constant of 1.9 x 10-9 M.
Approximately 80,000 receptors are present per cell, and this number is independent of cell
density.
Treatment of the cells with nerve growth factor reduces the amount of epidermal growth
factor binding by at least 809'0. The decrease in receptor binding begins after -12-18 h of nerve
growth factor treatment and is complete within 3 d. Scatchard plots indicate that the number
of binding sites decreases, not the affinity of the binding sites for epidermal growth factor.
The rat pheochromocytoma clone PC12 has been used exten-
sively as a model of neuronal differentiation. This clone,
developed from an adrenal tumor by Greene and his colleagues
(12, 18-20, 22, 45), is of adrenergic neural crest derivation. The
cells grow readily under standard conditions and exhibit many
of the properties of adrenal medullary chromaffin cells. In the
presence of nerve growth factor in nanogram or even subnan-
ogram amounts, the cells differentiate into a phenotype resem-
bling sympathetic neurons. The changes occur within a few
days and include process formation, electrical excitability,
amine uptake and storage, and a cessation of cell division. The
cells contain increased levels ofcertain transmitter-synthesizing
enzymes (13, 20, 41) and will make synapses with appropriate
target tissues (41). The differentiation appears to be reversible,
but except for this, it resembles, as far as has been explored,
the changes occurring in normal cells differentiating into sym-
pathetic neurons.
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The importance of this system for studies on nerve growth
factor is hard to exaggerate. In vitro work with nerve growth
factor has been limited for some time to experiments with
sympathetic or sensory neurons in culture. Such experiments
have been less than satisfactory because these neurons require
nerve growth factor for survival under these conditions. Thus,
any differences found between nerve growth factor-treated
tissue and controls could be charged simply to the fact that the
controls were dying. The PC 12 system, because it remains quite
healthy in the absence of nerve growth factor, provides a
unique in vitro tool for the study of nerve growth factor-
initiated changes.
The use of this system for the study of neuronal differentia-
tion is also of immense importance. Although there are some
reservations about the fidelity of this model, it does provide an
early and synchronized look at the events preceding, accom-
panying, or even participating in the decision point leading to
189the formation of a neuron. Also, it allows questions to be asked
about what events are initiated and what events are terminated
when the cell expresses neuronal properties. Such studies are
difficult if not impossible with normal cells because of the
inaccessibility of neurons or their precursor cells at such early
stages of development.
The recent observation (14, 30) that the PC 12 cell line
responds to epidermal growth factor as well as to nerve growth
factor provides a new dimension. Although epidermal growth
factor is generally isolated from the same source as is nerve
growth factor (2, 40), and shares some very general similarities
in its mode of biosynthesis and its subunit structure (21), the
proteins themselves are different both chemically and physi-
cally. More importantly, the effects of the two factors on their
respective target organs are very different. Epidermal growth
factor is a potent mitogen in many of its target tissues (7, 16).
Nerve growth factor, in PC 12 cells at least, is a terminal
differentiator and stops cell division. Indeed, even the early
observations, which led to the conclusion that nerve growth
factor had hyperplastic effects in normal ganglia (31), have
now been reinterpreted in the light of more recent studies (25).
Thus, the interaction between these two growth factors, with
apparently opposing effects in a single system, appeared worthy
ofstudy. This paper describes experiments designed to explore
the several actions of epidermal growth factor on PC12 cells,
to contrast them with the actions of nerve growth factor, and
to inspect the consequences of exposing the cell to both. The
results of these studies necessitated an investigation of the
epidermal growth factor receptor and the changes it undergoes
when the cells differentiate in response to nerve growth factor.
MATERIALS AND METHODS
Nerve growth factor was prepared by the method ofBocchini and Angeletti (2).
Nerve growth factor antiserum was raised in sheep by standard techniques and
stored as a lyophilized powder at -20°C. Epidermal growth factor was prepared
by the procedure ofSavage and Cohen (40). Epidermal growth factor antiserum
was purchased from Collaborative Research Inc., Waltham, Mass. PC12 cells
were obtained from Dr. Roseanne Goodman, School of Medicine, University of
California. Dulbecco's Modified Eagles Medium (Vogt modification) (DMEM)
and fetal calf serum were purchased from Grand Island Biological Co. (GIBCO,
Grand Island, N. Y.). DL-[1-"C]Omithine hydrochloride (45 mCi/mmol),
[methyl-'Hlthymidine (56.2 Ci/mmol), 2-[l,2'H]deoxy-D-glucose (40 Ci/mmol),
and L-[4,5-'H]leucine (5 Ci/mmol) were obtained from New England Nuclear,
Boston, Mass. Insulin and EDTA were purchased from Sigma Chemical Co., St.
Louis, Mo., hyamine hydroxide and ["'I]NaI from New England Nuclear,
dibutyryl cyclic adenosine monophosphate (dBcAMP) from Boehringer-Mann-
heim Biochemicals, Indianapolis, Ind., and pyridoxal phosphate and dithiothre-
itol from Calbiochem-Behring Corp., American Hoechst Corp., SanDiego, Calif
Cells were grown as monolayers in DMEM supplemented with 15% fetal calf
serum, 6 mM additional glutamine, penicillin (100 mU/ml), streptomycin (100
lLg/ml), and 25 mM HEPES. Themedium was changed twice a week and the
cells were generally split once a week in a 1:4 ratio. The cells were maintained in
tightly closed flasks at 37'C underan atmosphere sufficiently enriched with COZ
to maintain a slightly acidic pH in the medium.
Adhesion assays were performed in 25-cm' Falcon flasks (Falcon Labware,
Div. Becton, Dickinson & Co., Oxnard, Calif .) essentially by the method of
Schubert and Whitlock (43). PC12 cells weregrown overnight in the presence of
['H]leucine (2 ACi/ml). They were then rinsed and collected in a small volume of
fresh serum-free medium. The labeled cells were diluted with fresh serum-free
control medium or with medium containing the growth factors. This cell suspen-
sion was placed in empty Falcon flasks or in flasks containing a monolayer of
unlabeled PC12 cells. The cells were left at room temperature for 60 min and
then were given a standardized swirling of 10 revolutions on a metabolic shaker.
The unattached cells were poured off and the attached cells were collected in
fresh medium by vigorous shaking of the flasks. The cells were centrifuged and
washed twice with0.1 MTris-HCI, pH 7.4, containing 0.9%NaCI. Thecells were
then dispersed in fresh Tris-bufferedsaline and trichloroacetic acid was added to
a finalconcentrationof 10%. Theprecipitated proteinwas collected on Whatman
GFA glass fiber filters and washed with 5% trichloroacetic acid. The glass fiber
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discs were immersed in Liquafluor (Research Products International, Elk Grove
Village, Ill.) and counted in ascintillation counter.
The uptake of2-deoxyglucose was measured by a modification of the proce-
duredescribed by Hollenberg and Cuatrecasas (27) for the study of3-O-methyl-
D-glucose transport. PC12 cells cultured on 35-mm tissue culture dishes were
rinsed free of medium with warm phosphate-buffered saline (PBS) containing
0.1% bovine serum albumin (BSA). The cells were preincubated for 10 min at
24°C in l ml of PBS containing BSA. Then the test compounds were added,
together with tritiated 2-deoxyglucose, to a final concentration of 0.5 uCi/ml.
After 45 min at 24°C, the uptake was terminated by the addition of 1 ml of ice-
cold PBS containing phloretin (30 pg/ml). The cells were harvested by scraping
the dishes with a rubber policeman and a I ml portion of the cell suspension was
layered over 1.6 ml of 4% Ficoll made up in PBS. The tubes were centrifuged at
27,000 g for 5 min and the pellet was washed once in cold PBS. Ice-cold 5%
trichloroacetic acid was added to each pellet and the trichloroacetic acid precip-
itate was removed by centrifugation. Aportion of the supernatant fraction was
placed in a counting vial containing Aquasol (New England Nuclear) and the
radioactivity wasmeasured in a liquid scintillation spectrometer. Aportion ofthe
precipitate was used for estimation of the protein and aliquots of the original
suspension were used to obtain cellcounts. Values for the uptake of2-deoxyglu-
cose inthe presence ofphloretin (40pg/ml) were subtracted from the experimen-
tal values to correct for nonspecific effects.
Omithine decarboxylase was assayed by the method of Pegg and Williams-
Ashman (37) as modified by Oka and Perry (36). 5 h after the addition of the
appropriate growth factor to cells in 25-cm' Falcon flasks and 30 h after the last
medium change, the medium was removed and the cells collected in 4.5 ml of
cold 0.32 M sucrose containing 0.01 M Tris-HCI, pH 7.4. The cells were
centrifuged and washed twice with 4.5-ml portions ofcold sucrose-Tris. The cells
were then dispersed in 200 pl of the homogenizing buffer (50 mM Tris-HCI, pH
7.4, 5 mM dithiothreitol, 0.04 mM pyridoxal phosphate) and the suspension
frozen on dry ice. The frozen suspension was stored at -20'C overnight. The
next day, the suspension was thawed, homogenized in a ground glass homoge-
nizer, and centrifuged at 8,000 g for 15 min. The assay was performed on a
portion ofthe homogenized, centrifuged cell supernate in the presence of l I 1 fLM
DL-[1-"C]omithine(2.5 tLCi) in a total volume of0.5 ml. The reaction was carried
out in a rubber-stoppered tube with ahanging center well containing 0.2 ml of
hyamine hydroxide to absorb the labeled COz. Thereaction was terminated after
1 h at 37'C by injecting 0.6 ml of 2.5 M H2SO4 through the stopper, and the
tubes were allowed to equilibrate at room temperature overnight. The next day,
the hyamine-containing center well was placed in a scintillation vial containing
Liquafluor and the radioactivity measured in aliquid scintillation spectrometer.
To measure leucine or thymidine incorporation, we grew the cells in 35-mm
Costar tissue culture dishes (Costar, Data Packaging, Cambridge, Mass.). Triti-
ated thymidine (l pCi/ml) ortritiated leucine(1 uCi/ml) was added and the cells
kept at 37'C for 2 h. The incubation was terminated by the addition of 1 ml of
ice-cold PBS. The cells were harvested by scraping the dishes with a rubber
policeman. The cell suspensions were transferred to centrifuge tubes. Each dish
was washed with 1 ml offresh PBS, and the wash added to the cell suspension.
The cell suspensions were centrifuged at 1,000 gfor 5 min and washed twice with
PBS. Ice-cold trichloroacetic acid was added to the pellets and the tubes centri-
fuged at 27,000gfor 15 min. Aportion ofthe supernatant fraction was transferred
to a counting vialcontaining scintillant todetermine thymidine or leucine uptake
into the soluble compartment of the cells. Thepellet was partially digested by
heating for 30 min at 70'C in 0.5 ml of 10% perchloric acid to solubilize DNAor
in 0.5 ml of 0.5 N NaOH to solubilize protein. Aportion ofthe digest was added
to counting solution to determine the incorporation of the tritiated precursor.
Another portion was taken for DNAor protein determination.
Iodinated epidermal growth factor was prepared by the chloramine T-talcum
procedure of Cuatrecasas (11). The factor (4 pg) was added to 100 Id of 0.25 M
sodium phosphate, pH 7.4. Then, 20 pl ofchloramine T solution (5 mg/ml in
water) was added, followed by 5 pl of Na ...1 (2.5 mCi). The mixture was kept
for 40 s at room temperature and then 40Al ofsodium metabisulfite solution (10
mg/ml in water) was added. Themixture was diluted with 4ml of0.1 Msodium
phosphate, pH 7.4, containing 0.1% BSA. Talcum (25 mg) was added, and the
mixture was centrifuged at low speed. The talcum pellet was resuspended in five
successive 4 ml washings of 0.1 M sodium phosphate, pH 7.4, and collected by
centrifugation after each. Then the iodinated peptide was eluted with 3 ml of 0.4
M HCIcontaining 6% BSA. In practice, it was found necessary to filter the acid
before use to remove small amounts of undissolved albumin. The eluate was
centrifuged for 20 min at 8,000 gand the supernatant portion was removed and
neutralized with 0.5 M NaOH using pH paper to indicate the end point. In a
typical preparation, 5 pl contained 300,000 cpm which was at least 95%precipi-
table with 10% trichloroacetic acid.
The specific binding of epidermal growth factor was measured by adding
labeled epidermal growth factor to monolayer cultures of PC12 cells in fresh
growth medium. The cells were incubated at 37°C for 45 min, after which the
radioactive medium was removed by aspiration. The monolayers were rinsedtwice gently and rapidly with cold PBS. Then, 2 ml of 1 N NaOH were added to
disrupt the monclayer and the radioactivity contained in a 1-ml portion was
measured in a Searle model 1185 gamma counter (G. D. Searle & Co., Des
Plaines, Ill.). Specific binding was evaluated in each case by subtracting the
counts bound in duplicate flasks to which 500 ng/ml of unlabeled epidermal
growth factor had been added from the total binding.
Protein was determined either by the method of Lowry et al. (32) or by the
method ofBradford (3). DNA was measured by the method of Burton (4). Cell
numbers were estimated in a hemocytometer.
RESULTS
In the absence of growth factors, PC 12 cells showed a charac-
teristic round appearance under the phase-contrast microscope.
There was some flattening of the cells as they adhered to the
plastic substrate. After treatment with nerve growth factor,
there was a noticeable increase in the number of phase-dark,
flattened cells within 2-4 h. After the next several days ofnerve
growth factor treatment, thin neurites appeared which attained
a length of several microns and eventually formed a thick
network between the cells. Treatment with epidermal growth
factor produced an initial darkening and flattening of the cells,
similar to, but not as pronounced as, the flattening observed
with nerve growth factor. However, even after several days of
treatment with epidermal growth factor, there was little or no
evidence ofneurite production. In the presence ofboth factors,
there appeared to be more initial flattening of the cells than
with either alone, but the pattern of neurite formation was
indistinguishable from that seen with nerve growth factor
alone.
The flattening seen after treatment of the cells with either
nerve growth or epidermal growth factor was reflected in an
increased adhesiveness of the treated cells. When cells were
labeled overnight and then treated for 1 h with nerve growth
factor, they adhered more firmly to a monolayer of attached
PC 12 cells than did labeled cells that had not been so treated
(Table I). Treatment with epidermal growth factor had a
similar but less pronounced effect. The combination ofthe two
factors was frequently more effective in this regard than either
factor alone, but the increases were not additive. Dibutyryl
cyclic AMP also produced an increase in the adhesion of
labeled PC 12 to a monolayer. Similar experiments were per-
formed with only the plastic dish as substrate. The differences
in adhesion of the labeled cells to plastic were not as marked
as those seen when a monolayer was used, but they were in the
same order and the same direction as the measurements pre-
sented in Table I.
Within 45 min after the addition of either nerve growth
factor (Fig. 1 A) or epidermal growth factor (Fig. 1 B), the
uptake of 2-deoxyglucose into the cells was increased. The
stimulation in each case was concentration-dependent and
appeared to be maximal at -500 ng of nerve growth factor/ml
and 50 ng of epidermal growth factor/ml.
Several hours after the addition ofnerve growth factor, there
wasa marked increase in the activity ofornithine decarboxylase
in the cells (Table II). With epidermal growth factor, there was
also an induction of ornithine decarboxylase, although not so
marked as that seen after nerve growth factor (Table II). These
levels of induction were maximal; increases in the concentra-
tion of either growth factor did not produce increases in the
levels of ornithine decarboxylase found. Thus, the ability of
nerve growth factor to induce ornithine decarboxylase was
severalfold greater than the ability ofepidermal growth factor
to induce what is presumably the same enzyme. The combi-
nation of nerve growth factor and epidermal growth factor
PC12 cells were labeled overnight with [3H]leucine and adhesion assays were
performed as described in Materials and Methods. Additions were: nerve
growth factor, 100 ng/ml; epidermal growth factor, 150 ng/ml; dibutyryl cyclic
AMP, 1 mM. Values reported as means (n = 3) t SEM.
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TABLE I
Adhesion of Labeled PC12 Cells to a Monolayer of Unlabeled
PC12 Cells in the Presence of Nerve Growth Factor or
Epidermal Growth Factor.
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FIGURE 1
￿
Stimulation of [3H]2-deoxy-D-glucose uptake into PC12
cells by nerve growth factor (A) and by epidermal growth factor
(8) . PC12 were grown in 35-mm culture dishes. Nerve growth factor
and [3H]deoxyglucose (0.5 pCi) were added in 1 .0 ml of phosphate-
buffered saline containing 0.1% bovine serum albumin. After 45
minutes, the cells were harvested andtreated with 5% trichloroacetic
acid. The soluble radioactivity was measured. Parallel cell mono-
layers were treated with phloretin (30 ttg/ml) to correct for [3H]-
deoxyglucose accumulation not mediated by the hexose carrier.
Values reported as means (n = 4). Brackets indicate SEM.
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Nerve Growth Factor, Epidermal Growth Factor, and PC12 Cells
Cell adhering
100
None 36.8 t 2.4
Nerve growth factor 68.6 t 1 .3
Epidermal growth factor 55.0 t 1 .4
Nerve growth factor + epidermal growth factor 73.1 t 2.3
Dibutyryl cyclic AMP 71.6 t 7.8TABLE II
Effect of Nerve Growth Factor, Epidermal Growth Factor, and
of Specific Antisera on Ornithine Decarboxylase Activity in
PC12 Cells
Cells were treated for 6 h and ornithine decarboxylase assays were performed
as described in Materials and Methods. Additions were: nerve growth factor,
30 ng/ml; epidermal growth factor, 150 ng/ml; antisera, 0.1 ml, full strength.
Antisera were preincubated with the relevant growth factors for 30 min at
room temperature before adding them to the medium. Values reported as
means (n = 3) t SEM.
seemed to produce a greater induction than either alone in
several experiments, although the variability of the actual
induction andthemuch greater magnitudeofthenervegrowth
factor induction made it difficult to determine if these induc-
tions were additive.
To provethat the induction by each factor was independent,
and not a result of contamination of one factor by the other,
antibody experiments were performed(Table II). It was shown
that nerve growth factor antiserum blockedthe action of nerve
growth factor on ornithine decarboxylase induction by >90%,
but epidermal growth factor antiserum had no effect. The
reverse was true of the epidermal growth factor response. It
was blocked by ^-60% by epidermal growth factor antiserum,
butwasnotinfluenced by nervegrowth factor antiserum. Thus,
the difference in the maximal activity elicited by each factor,
the additional activity elicited by one in the presence of the
other, and the specificity of each antiserum indicates that the
cells are responding independently to each factor and not to
one factor as a contaminant of theother.
As mentioned earlier, the presence of nerve growth factor
and epidermal growth factor together gave the appearance,
morphologically, of the presence of nerve growth factor alone.
To understand this relationship fully, experiments were per-
formed in which the biological response to one factor was
measured after treatmentwith the other. Cells pretreated with
epidermal growth factor for 3 d were then exposed to nerve
growth factor. The induction of ornithine decarboxylase was
similar to that seen in untreated cells when similarly exposed
to nerve growth factor (Table III). The reverse, however, was
not true. Cells treated for 3 d with nerve growth factor had a
much lower response to epidermal growth factor than did
untreated cells (Table IV). The increase in treated cells was
<20°lo of that in controls in most experiments. That this was
not because of some general inability of the nerve growth
factor-treated cells to respond was shown by the fact that
ornithinedecarboxylase induction by dibutyrylcyclic AMP in
nerve growth factor-treated cells was the same as that seen in
untreated cells (Table IV).
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After several days of treatment, the cultures treated with
nervegrowth factor showed different characteristics than those
treatedwith epidermalgrowth factor.In addition to theobvious
difference in morphology, there also appeared to be some
difference in cell numbers. After 96 h, cell proliferation, as
estimated by the number of cells (Fig. 2A) and thetotal DNA
(Fig. 2B) in each culture dish, was moderately stimulated by
epidermal growth factor and moderately inhibited by nerve
growth factor. Neither treatmentproduced effectson cell num-
bers or DNA content which differed significantly from un-
treated controls, even after 96 h of treatment. However, the
divergence in cell number and total DNA between epidermal
growth factor-treated and nerve growth factor-treated cultures
was statistically significant (P < 0.05 by analysis of variance
combined with Duncan's multiple range tests). Although some
initial increases in the uptake of [3H]thymidine into the intra-
cellular acid-soluble pool were noted in both nerve growth
factor-treated and epidermal growth factor-treated cells, there
were no significant differences in the uptake of tritiated thy-
midine into the cells or in the incorporation of [3H]thymidine
into the DNA after 72 h oftreatment (Table V).
Nervegrowth factor produced itscharacteristic hypertrophic
effect on the cells, as evidenced by a marked increase in the
amount of protein per cell (Fig. 2C). Epidermalgrowth factor
TABLE III
Effect of Nerve Growth Factor on Ornithine Decarboxylase
Activity in Control andin Epidermal Growth Factor-treated
PC12 Cells
Ornithine
decarboxyl-
Cells were grown for 3 d alone or in the presence of epidermal growth factor
(150 ng/ml). The medium was changed, and fresh epidermal growth factor
was added on the 2nd day. Nerve growth factor (30 ng/ml) was added and
the cells harvested 6 h later. Values reported as means (n = 3) t SEM.
TABLE IV
Effect of Epidermal Growth Factor andof Dibutyryl Cyclic
AMP on Omithine Decarboxylase Activity in Control and in
Nerve Growth Factor-treated PC12 Cells
Ornithine
decarboxyl-
Cells were grown for 3 d alone or in nerve growth factor (30 ng/ml) . The
medium was changed, and fresh nerve growth factor was added on the 2nd
day. Epidermal growth factor (150 ng/ml) or dibutyryl cyclic AMP (1 mM) was
added and the cells harvested 6 h later. Values reported as means (n = 3) t
SEM.
Treatment
Ornithine decar-
boxylase activity
pmol [ "C02
] re-
leasedliag protein
None 0.6 t 0.1
Nerve growth factor 19.2 t 2.2
Nerve growth factor + nerve growth factor 2.6 t 0.6
antiserum
Nerve growth factor + epidermal growth 21 .7 ± 4.0
factor antiserum
Epidermal growth factor 5.5 t 0.6
Epidermal growth factor + nerve growth 6.4 t 0.6
factor antiserum
Epidermal growth factor + epidermal 2.8 t 0.5
growth factor antiserum
Nerve growth factor + epidermal growth 24.6 t 4.3
factor
Cells Treatment ase activity
pmo! [' ° C021
releasedlAg
protein
Control None 0.9 t 0.1
Epidermal growth factor 5.7 t 0.3
Dibutyryl cyclic AMP 5.6 t 0.9
Nerve growth factor- None 1.1 ±0.1
treated
Epidermal growth factor 2.4 t 0.1
Dibutyryl cyclic AMP 6.5 t 0.5
Cells Treatment ase activity
pmol ["C021
releasedlug
protein
Control None 1 .8 ± 0.3
Nervegrowth factor 9.9 t 1 .8
Epidermal growth factor- None 3.4 t 0.4
treated
Nervegrowth factor 15.3 ± 1 .7w 50
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Effect of Nerve Growth Factor or Epidermal Growth Factor on
Thymidine Uptake and Thymidine Incorporation in PC12 Cells
Cells were grown for 72 h in the presence of the indicated levels of the factors.
The cells were then incubated for 2 h with 1 IuCi of [3H)thymidine/ml. The
cells were harvested, washed, and treated with 5% trichloroacetic acid. The
acid-soluble and acid-precipitable radioactivity were measured as described
in Materials and Methods. Values were normalized to the total DNA in the
culture. Values reported are the mean (n =3) t SEM.
had no comparable effect. Nerve growth factor caused a cor-
responding increase in the amount of leucine incorporated per
cell (Table VI), but no substantial increase when the incorpo-
ration was normalized to cellular protein. Epidermal growth
factor produced small, fairly consistent increases in the rate of
protein synthesis per cell as evidenced by the increased specific
activity of the protein isolated from epidermal growth factor-
treated cells. No consistent increases in leucine uptake into the
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FIGURE 2
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(A) Proliferation of cells treated with nervegrowth factor
or epidermal growth factor. Cells grown in 35-mm tissue culture
dishes were counted using a hemocytometer. Each point represents
the mean of six culture dishes. ( 8) DNA content of cultures treated
with nerve growth factor or epidermal growth factor. Cells were
grown in 35-mm tissue culture dishes, collected at the indicated
times, and the DNA precipitated with 5% trichloroacetic acid. The
precipitate was heated in 10% perchloric acid, and the extract
reacted with diphenylamine for the colorimetric determination of
DNA. Each point represents the mean of three culture dishes. (C)
Protein content of cells treated with nerve growth factor or epider-
mal growth factor. Cells were grown in 35-mm tissue culture dishes,
collected at the indicated times, and the proteins precipitated with
5% trichloroacetic acid . After digestion of the precipitates with
NaOH, the protein was determined colorimetrically. Values were
normalized to cell number. Each point represents the mean of three
culture dishes.
TABLE VI
Effect of Nerve Growth Factor or Epidermal Growth Factor on
Leucine Uptake and Leucine Incorporation in PC12 Cells
gprotein
5 t 2.1
8 t 8.0
3 ± 3.3
9 t 10.6
factor, 10 nglml
Epidermal growth
￿
49.0 t 6.6
￿
4,330 t 870
￿
62.3 t 12.9
factor, 100 nglml
Cells were grown for 72 h in the presence of the indicated levels of the factors.
The cells were then incubated for 2 h with 1 pCi of t3H)leucine/ml. The cells
were harvested, washed, and treated with 5% trichloroacetic acid. The acid-
soluble and acid-precipitable radioactivity were measured as described in
Materials and Methods. Values reported are the means (n =3) t SEM.
acid-soluble pool were seen after 72 h treatment with either
factor, although epidermal growth factor stimulated such up-
take at earlier times.
The binding of iodinated epidermal growth factor to PC12
cells could be inhibited by low concentrations of native epi-
dermal growth factor (Fig. 3). This displacement was concen-
tration dependent and saturable. The specific binding of radi-
ET AL .
￿
Nerve Growth Factor, Epidermal Growth Factor, andPC12 Cells
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Treatment
None
Thymidine
Uptake Incorporation
cpm/lag DNA
1,361 t 376 15,433 t 4,024
Treatment Uptake
cpm/lag
protein
Leucine
Incorporation
cpml 10 6 cells cpm/l
Nerve growth factor, 10 ng/ml 1,352 t 180 18,163 t642 None 38.7 t 6.4 3,450 ± 920 40
Nerve growth factor, 100 ng/ml 1,227 t 196 18,793 t741 Nerve growth factor, 46.7 t 11 .5 12,800 t 990 54
Epidermal growth factor, 10 ngl 1,421 t 260 15,356 t 1,016 10 ng/ml
ml Nerve growth factor, 26.3 t 3.6 9,270 ± 1,700 43
Epidermal growth factor, 100ngl 1,050 t 274 21,508 t 8,089 100 nglml
ml Epidermal growth 38.4 t 5.1 5,540 t 1,600 57oiodinated epidermal growth factor accounted for 80-95% of
the total radioactivity bound to the cells. The rapid, initial
binding of iodinated epidermal growth factor was complete
within 40 min, although a slower gradual increase in the
radioactivity associated with the cells was apparent for at least
another hour (Fig. 4). The binding was quite specific for
epidermal growth factor (Table VII). Neither nerve growth
factor, cytochrome c, insulin, nor growth hormone in large
amounts displaced labeled epidermal growth factor. Finally,
the binding of epidermal growth factor to PC 12 cells was
independent of cell density (Fig. 5).
Treatment of cells with nerve growth factor markedly re-
duced the binding of epidermal growth factor (Fig. 6). A
latency period of at least 9 h passed before the reduction in
0
z
30
FIGURE 3
￿
Concentration dependence of the binding of epidermal
growth factor to PC12 cells. Approximately 0.5 ng of iodinated
epidermal growth factor (-763,000 dpm) and the indicated amounts
of native epidermal growth factor were added to PC12 cultures in
2 ml of medium . After 45 min the cells were collected and the
associated radioactivity counted. Each point represents the mean of
four determinations. Brackets indicate SD.
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FIGURE 4 Time-course of the binding of iodinated epidermal
growth factor to PC12 cells. Binding was done with 0.4 ng (135,000
dpm) of iodinated epidermal growth factor. Nonspecific binding,
i.e., binding in the presence of 500 ng/ml of unlabeled epidermal
growth factor, wassubtracted from each point. Each point represents
the mean of three determinations. Brackets indicate SD.
TABLE VII
Specificity of
1251-Epidermal Growth Factor Binding to PC12
Cells
TIME (dao)
Iodinated epidermal growth factor (0 .44 ng, 420,000dpm) was added in the
presence of various unlabeled proteins. Data represent the means (n =4) t
SEM.
FIGURE 5
￿
Lack of effect of cell density on the binding of iodinated
epidermal growth factor to PC12 cells. PC12 cells were plated at an
initial density of 5 x 105 cells per 25-cm2 tissue culture flask and
grown for 6 d under the conditions described in Materials and
Methods. Binding was evaluated with 0.62 ng (521,000 dpm) of
iodinated epidermal growth factor. Each point represents the mean
of five determinations. Brackets indicate SD.
binding was observed. After the latency period, a time-depend-
ent decrease in binding occurred, which resulted in an 80%
reduction of epidermal growth factor binding within 72 h. In
view of the nerve growth factor-induced hypertrophy of the
cells, which resulted in a doubling of cell protein content, the
results were also expressed in terms of cell number (Table
VIII). In these terms, the decrease in epidermal growth factor
binding was still apparent. The effects of nerve growth factor
were concentration-dependent up to 20 ng/ml (Fig. 7). Kinetic
analysis of the nerve growth factor-induced reduction in epi-
dermal growth factor binding (Fig. 8) revealed that nerve
growth factor reduced the number of binding sites, rather than
altering their affinity for the ligand. Least squares linear regres-
sion analysis of the Scatchard plots (Fig. 9) yielded correlation
coefficients of 0.840 and 0.889 for the binding data obtained
from nerve growth factor-treated and untreated cells, respec-
tively. The apparent dissociation constants were 1.97 x 10-9 M
and 1 .91 x 10-9 M, respectively. Treatment of cells with nerve
growth factor reduced the number of epidermal growth factor
binding sites in this experiment from 79,640 binding sites per
cell to 42,680 binding sites per cell. It should be noted here
that this experiment involved 24 h of nerve growth factor
treatment rather than 72. After 72 h, the amount of epidermal
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None 142.5 t 4.3
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Insulin, 100leglml 152.0 t 7.3
Cytochrome c, 100 pglml 139.0 t 2.4
Growth hormone, 1001Lglml 135.1 t 5.8DISCUSSION
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FIGURE 6
￿
Time-course of nerve growth factor-induced loss of epi-
dermal growth factor binding to PC12 cells. Cells were grown in
control medium or in nerve growth factor-containing medium, 50
or 500 ng/ml. Binding of iodinated epidermal growth factor (0.5 ng,
415,000 dpm) was measured at the indicated times. Each point
represents the mean of four determinations. Brackets indicate SD.
The inset presents data for the loss of epidermal growth factor
binding for the first 24 h after treatment with 100 ng/ml of nerve
growth factor.
TABLE VIII
Reduction of Epidermal Growth Factor Binding in Nerve
Growth Factor-treated Cells
Epidermal growth factor bind-
Cells
￿
ing
dpm/lag protein
￿
dpm/10 3 cells
Control
￿
50.2 9,045
Nerve growth factor-treated
￿
5.5
￿
1,972
Cells were grown in control medium or in nerve growth factor-containing
medium (500 ng/ml) for 72 h. Data from Fig. 4.
growth factor binding was so low that kinetic analysis became
difficult.
Epidermal growth factor is a potent mitogen for a number of
cell types (7, 16). It stimulates epithelial and endothelial cell
proliferation, and interacts with receptors on cells of different
derivation from a number of species. The biochemical re-
sponses it elicits include rapid increases in the transport of
small molecules (1, 26, 27, 38), increases in the phosphorylation
of membrane (8) and nuclear proteins (29), and increases in
the synthesis of RNA and proteins (10, 26). All responses,
however, are not found in all cells that interact with epidermal
growth factor, and indeed, some cells have easily demonstrable
receptors for epidermal growth factor but exhibit no substantial
mitogenic response under the conditions studied.
Very few neural-type cells are known to respond to epider-
mal growth factor. It had been shown that human glial cells
exhibit a density-dependent response to epidermal growth
factor in serum-free medium (46). This response includes in-
creases in multiplication rate and in thymidine incorporation.
And, during this work, it has been reported (15) that epidermal
growth factor induces tyrosine hydroxylase in PC-G2, another
HUFF ET
clone from rat pheochromocytoma. But the original observa-
tion that PC 12 cells respond was a bit unexpected.
On the other hand, the response of PC12 to nerve growth
factor has been well characterized. This response includes
increases in cellular adhesiveness (43), changes in membrane
structure (9) and in membrane proteins (34), alterations in
cyclic nucleotide levels (43), increases in the transport of small
molecules (33), induction of ornithine decarboxylase (17, 24,
30), alterations in the phosphorylation of nuclear proteins (47),
and induction of transmitter-synthesizing enzymes (13, 20, 41).
The cells develop excitable membranes (12), grow processes
(45), and stop dividing (22). Overall, the response to nerve
growth factor can be characterized as the terminal differentia-
tion ofa nonneuronal cell into a sympathetic neuron, although
it differs from normal cell differentiation in the one vital
respect that it is reversible.
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of epidermal growth factor binding to PC12 cells. Cells were grown
in various concentrations of nerve growth factor as described in
Materials and Methods. Binding of iodinated epidermal growth
factor (0.12 ng, 117,000 dpm) was measured after 24 h. Each point
represents the mean of four determinations. Brackets indicate SD.
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FIGURE 8 Concentration dependence of epidermal growth factor
binding to control and to nerve growth factor-treated PC12 cells.
Cells were treated with 100 ng/ml of nerve growth factor for 24 h.
Indicated concentrations of native epidermal growth factor were
mixed with iodinated epidermal growth factor (0.06 ng, 793,000
dpm) . Binding was measured as described in Materials and Methods.
Each point represents the mean of duplicate determinations.
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decrease in epidermal growth factor binding. Constructed from data
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Thus, the effects of epidermal growth factor in other test
systems are quite different than the known effects of nerve
growth factor in PC 12 cells. Nevertheless, these two peptides
produce some apparently similar responses in these cells.
One of these responses is an increased cellular adhesion.
Both peptides increase the ability of the PC12 cells to adhere
to plastic or to each other. This finding does not support the
concept that increased adhesion is prelude to neurite outgrowth
(42) because epidermal growth factor produces little or no
neurite formation. It does not, however, preclude the possibility
that the two factors are increasing adhesiveness by different
mechanisms. The observation that the increases produced by
the two factors together were frequently greater than that
produced by either alone suggests that the action of each may
be different. Because so little is known about the molecular
basis of the alterations in the membrane underlying adhesive-
ness, this question seems a difficult one to answer.
Another common response is an increase in the uptake of 2-
deoxyglucose. Neitherincrease is unexpected because increases
in the transport of small molecules, and specifically in the
transport of monosaccharides, have been reported as conse-
quences of the action of both nerve growth factor (28) and
epidermal growth factor (2'7) on their respective target cells.
A third apparently common response is the increase in
ornithine decarboxylase activity. This enzyme is rate-limiting
for the synthesis of polyamines, and has been implicated in a
variety ofcellular changes including malignant transformations
and hormonal responses (39, 44). Whatever its function or
functions in the cell, it appears to be an excellent indicator of
changes in nuclear activity. Both peptides produce an increase
in the activity of the enzyme, presumably an induction. The
increase, caused by epidermal growth factor, is less than the
increase caused by nerve growth factor even with maximal
amounts of each in the medium. This may suggest that they
are working on the regulatory system controlling the induction
in different ways. Support for this concept can be found in the
frequent observation that the induction by the two factors
together is greater than that by either alone. Again, because
ornithine decarboxylase has been implicated in many different
processes in various cells, there is no certainty that the induc-
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tion by two different factors means that the factors produce
the same end results in the cell. Incidentally, the observation
that epidermal growth factor induces ornithine decarboxylase,
but doesn't produce neurite outgrowth, supports previous stud-
ies (17) showing a dissociation between these two events, both
ofwhich are consequences ofthe action of nerve growth factor.
It is known that nerve growth factor inhibits or terminates
cell division in PC 12 cells (22). The observation here that cell
proliferation in nerve growth factor-treated cultures is lower
than that in controls is consistent with these previous obser-
vations. The modest stimulation ofcell proliferation produced
by the epidermal growth factor, although not convincing evi-
dence that epidermal growth factor has mitogenic action in
these cells, is distinct from the effect of nerve growth factor.
The possible mitogenic effects of epidermal growth factor may
have been masked by the culture conditions, i.e., 15% fetal calf
serum. It is clear from work in other systems that the magnitude
ofthe epidermal growth factor effect on thymidine incorpora-
tion and cell division is markedly influenced by the culture
conditions, more specifically, by the serum level (7). Reducing
the serum concentration in the growth medium is a manipu-
lation that has been used to slow cell proliferation and, hence,
unmask the mitogenic response to epidermal growth factor. It
is reasonable to ask, however, whether epidermal growth factor
actually initiates a mitogenic response or simply maintains cell
viability under such suboptimal conditions.
As mentioned before, the addition of epidermal growth
factor and nerve growth factor together results in cells with
morphological characteristics indistinguishable from those
treated with nerve growth factor alone. Indeed, the cells appear
to stop growing and cell counts reveal, again, a similarity to
those treated only with nerve growth factor. It appears, then,
that the action of nerve growth factor predominates and it
becomes of interest to inquire into the mechanism mediating
this effect.
The observation that the cells treated with nerve growth
factor do not respond to epidermal growth factor with as
substantial an induction of ornithine decarboxylase as do un-
treated cells suggests that the nerve growth factor in some way
limits the intracellular biological response to epidermal growth
factor. This is consistent with the predominance of nerve
growth factor. The fact that a cells treated with nerve growth
factor respond normally to dibutyryl cyclic AMP shows that
the lowered response to epidermal growth factor is a specific
inhibition and does not reflect some artifactual refractoriness
to ornithine decarboxylase in these treated cells. Parentheti-
cally, it seems worth mentioning that in these experiments the
cells were treated for 3 d to fully influence them with nerve
growth factor and to allow ornithine decarboxylase levels to
come back to baseline after induction by the nerve growth
factor itself (17), that the medium was changed fully 24 h
before the addition of epidermal growth factor to avoid any
increases in ornithine decarboxylase caused simply by the
addition of fresh medium, and that nerve growth factor was
kept in the medium continually because of the reversibility of
nerve growth factor effects in these cells.
Thus, nerve growth factor and epidermal growth factor act
independently on PC 12 cells, although some of the conse-
quences of the actions of the two peptide factors on these cells
are the same. That is, both increase cellular adhesion, 2-deoxy-
glucose uptake, and ornithine decarboxylase levels. But epi-
dermal growth factor has a mild proliferative action on the
cells and nerve growth factor induces hypertrophy and aterminal differentiation. Nerve growth factor actions predom-
inate when the two factors are added together and nerve growth
factor treatment of the cells limits the biological response of
the cells to epidermal growth factor.
The epidermal growth factor receptors on PC12 cells seem
unremarkable. The apparent equilibrium constant of 1 .9 x
10-9 is on the order ofsimilar constants reported for epidermal
growth factor receptors on other cells (5, 6, 26, 35); the number
of receptors per cell is approximately the same as that found
on cultured human fibroblasts (5, 26). The specificity for
epidermal growth factor has not been done in detail here, but
it is important to note, in view of the functional interaction
between the two factors, that nerve growth factor has no
apparent affinity for the epidermal growth factor receptor.
The reason that the cells treated with nerve growth factor
exhibit a reduced response to epidermal growth factor appears
to be that there is a diminished amount of epidermal growth
factor binding to the treated cells. That is, the biological
response to epidermal growth factor is diminished by a reduc-
tion of cellular receptors after nerve growth factor treatment.
There are now numerous examples of cells that have lost
epidermal growth factor receptors for one reason or another
and exhibit a parallel loss of biological response to the factor
(6, 23, 35). This is the first case, however, of a loss of receptors
caused by a differentiating stimulus. The concentration de-
pendence of the receptor loss, virtually a complete effect at
-20 ng of nerve growth factor/ml, again suggests that the
interaction is not caused by a direct competition for the recep-
tor. The time-course of the loss, a 9-h lag followed by a
complete loss over a 3-d period, indicates that the loss is caused
by some long-term, perhaps transcriptional alteration in the
synthesis of the receptor, and not a short-term alteration in the
conformation of the membrane. This seems consistent with the
Scatchard data which indicate a loss of receptors rather than
an alteration in their affinity.
One interpretation of the data is that the nerve growth factor
acts on PC 12 cells to terminate their cell division by, at least in
part, limiting their receptors for, and their response to, epider-
mal growth factor, a known mitogen. A mild extrapolation of
such a concept might lead to the suggestion that differentiating
agents cause, as part of their action, a lowered response to
mitogens by a similar mechanism. A bolder extrapolation
would be that cells destined to become neurons respond, at
some early point of decision, to nerve growth factor by limiting
their response to mitogens and, thus, become neurons.
Another interpretation is that nerve growth factor usurps the
trophic influences of epidermal growth factor at the level of
the membrane receptor before the expression of the differen-
tiated phenotype of the sympathetic neuron. While epidermal
growth factor did enhance the proliferation of PC 12 cells
modestly, its major effects ofincreased 2-deoxyglucose uptake,
increased cellular adhesion, and induction of omithine decar-
boxylase are shared by nerve growth factor and resemble a
generalized set oftrophic responses which enhance the survival
of the cells. In transferring the regulation of trophic function
to the differentiating stimulus, nerve growth factor, basic cel-
lular processes may be better synchronized with the event of
differentiation. Experiments with embryonic tissue are under-
way to test these hypotheses.
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